SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $282,000 | +23.1% | 2,554 | -16.4% | 0.02% | +26.3% |
| Q2 2022 | $229,000 | -3.8% | 3,054 | +0.3% | 0.02% | +11.8% |
| Q1 2022 | $238,000 | -13.1% | 3,044 | -0.1% | 0.02% | -15.0% |
| Q4 2021 | $274,000 | -2.5% | 3,047 | +0.1% | 0.02% | -16.7% |
| Q3 2021 | $281,000 | +23.2% | 3,043 | +3.9% | 0.02% | +20.0% |
| Q2 2021 | $228,000 | +5.1% | 2,928 | +0.3% | 0.02% | -9.1% |
| Q1 2021 | $217,000 | -49.3% | 2,918 | +16.3% | 0.02% | -56.0% |
| Q4 2020 | $428,000 | +21.6% | 2,509 | +0.2% | 0.05% | +2.0% |
| Q3 2020 | $352,000 | -40.6% | 2,505 | -32.3% | 0.05% | -47.9% |
| Q2 2020 | $593,000 | +47.5% | 3,700 | 0.0% | 0.09% | +25.3% |
| Q1 2020 | $402,000 | -54.8% | 3,700 | -32.8% | 0.08% | -65.8% |
| Q3 2018 | $889,000 | +215.2% | 5,503 | +115.5% | 0.22% | +812.5% |
| Q3 2011 | $282,000 | – | 2,554 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |